Panacea Biotec Limited has informed the Exchange regarding 'Details of Shares dematerialized during April 2026 under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018'.
PANACEABIO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Panacea Biotec has filed its monthly dematerialization status report for April 2026. The company confirms that no new shares were dematerialized during the month of April 2026. As of April 30, 2026, total dematerialized shares stood at 61,104,526 (NSDL: 53,644,500 shares + CDSL: 7,460,026 shares). Compared to March 31, 2026, there was a minor shift of 92,865 shares from CDSL to NSDL, but the total remained unchanged. This is a routine regulatory compliance filing required under SEBI regulations, with the certificate provided by the company's RTA, Skyline Financial Services Pvt. Ltd.
This filing has no direct impact on shareholders or stock price as it is purely a routine compliance submission. The dematerialized share count confirms the company's capital structure status for regulatory records.